Sanofi (SNY) News Today $52.40 -0.70 (-1.32%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 5:45 PM | seekingalpha.comNovavax Ahead Of Q2 Earnings - Picking Apart The Sanofi DealJuly 26 at 12:38 PM | marketbeat.comSanofi (NASDAQ:SNY) Receives Average Recommendation of "Hold" from BrokeragesShares of Sanofi (NASDAQ:SNY - Get Free Report) have received a consensus rating of "Hold" from the five ratings firms that are presently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and two have assigned a buy recoJuly 26 at 11:26 AM | marketbeat.comSanofi (NASDAQ:SNY) Price Target Increased to $60.00 by Analysts at ArgusArgus boosted their price objective on Sanofi from $55.00 to $60.00 and gave the stock a "buy" rating in a report on Friday.July 25 at 10:57 AM | globenewswire.comPress Release: Online availability of Sanofi's half-year financial report for 2024July 25 at 8:39 AM | markets.businessinsider.comSanofi Q2 Profit Down, Sales Rise; Lifts FY24 Business EPS ViewJuly 25 at 8:39 AM | msn.comSanofi lifts FY guidance after strong Q2 resultsJuly 25 at 8:39 AM | msn.comSanofi Non-GAAP EPS of €1.73, revenue of €10.74B; raises FY24 EPS outlookJuly 25 at 8:39 AM | finance.yahoo.comSanofi Raises 2024 Profit Outlook On Strong Q2 Earnings, Blockbuster Drug Dupixent Sees Strong DemandJuly 25 at 8:13 AM | seekingalpha.comSanofi 2024 Q2 - Results - Earnings Call PresentationJuly 25 at 1:37 AM | reuters.comSanofi bumps up full-year forecast after strong Q2 profitJuly 24 at 12:37 PM | finance.yahoo.comThe Zacks Analyst Blog Highlights Boston Scientific, Thermo Fisher Scientific, Align Technology and Edwards LifesciencesJuly 23 at 4:42 PM | benzinga.comSanofi (NASDAQ:SNY) Stock Quotes, Forecast and News SummaryJuly 23 at 11:41 AM | msn.comMerck RSV therapy succeeds in infants in challenge to Sanofi, AstraJuly 23 at 4:05 AM | benzinga.comAstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China StrifeJuly 22, 2024 | finance.yahoo.comSNY Aug 2024 40.000 call (SNY240816C00040000)July 22, 2024 | finance.yahoo.comSNY Aug 2024 40.000 put (SNY240816P00040000)July 18, 2024 | americanbankingnews.comSanofi (SNY) Scheduled to Post Quarterly Earnings on ThursdayJuly 17, 2024 | marketbeat.comBleakley Financial Group LLC Raises Holdings in Sanofi (NASDAQ:SNY)Bleakley Financial Group LLC boosted its stake in Sanofi (NASDAQ:SNY - Free Report) by 12.4% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 108,373 shares of the company's stock after buying an additional 11,949 shares duJuly 17, 2024 | globenewswire.comPress Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia AJuly 17, 2024 | investorplace.comStable Blue-Chip Stocks to Buy Before Earnings SeasonJuly 17, 2024 | reuters.comSanofi to invest $437 mln in India global centre, double its workforceJuly 16, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Shares Bought by Russell Investments Group Ltd.Russell Investments Group Ltd. lifted its holdings in Sanofi (NASDAQ:SNY - Free Report) by 8,492.4% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 616,506 shares of the company's stock after purchasing an additionalJuly 14, 2024 | marketbeat.comOppenheimer Asset Management Inc. Has $5.90 Million Position in Sanofi (NASDAQ:SNY)Oppenheimer Asset Management Inc. decreased its holdings in shares of Sanofi (NASDAQ:SNY - Free Report) by 13.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 121,296 shares of the company'sJuly 13, 2024 | marketbeat.comEquity Investment Corp Grows Stock Holdings in Sanofi (NASDAQ:SNY)Equity Investment Corp grew its holdings in Sanofi (NASDAQ:SNY - Free Report) by 23.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,393,474 shares of the company's stock after acquiring an additional 447,872 shares dJuly 13, 2024 | 247wallst.comFour Blue Chip Stocks To Buy Now And Hold For ForeverJuly 11, 2024 | marketbeat.comSanofi Target of Unusually Large Options Trading (NASDAQ:SNY)Sanofi (NASDAQ:SNY - Get Free Report) was the recipient of unusually large options trading activity on Thursday. Investors acquired 6,242 call options on the stock. This is an increase of approximately 276% compared to the typical volume of 1,658 call options.July 10, 2024 | prnewswire.comSanofi ships U.S. influenza vaccines for the 2024/25 seasonJuly 9, 2024 | marketbeat.comCentral Pacific Bank Trust Division Buys Shares of 26,500 Sanofi (NASDAQ:SNY)Central Pacific Bank Trust Division bought a new stake in Sanofi (NASDAQ:SNY - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 26,500 shares of the company's stock, valued at approximately $1,280,000. Other heJuly 9, 2024 | investorplace.com3 Stocks to Sell Immediately Based on the French Election ResultsJuly 7, 2024 | marketbeat.comCapstone Investment Advisors LLC Purchases New Stake in Sanofi (NASDAQ:SNY)Capstone Investment Advisors LLC purchased a new stake in Sanofi (NASDAQ:SNY - Free Report) during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 18,939 shares of the company's stock, valued at approximately $920July 6, 2024 | marketbeat.comBNP Paribas Financial Markets Has $50.23 Million Stake in Sanofi (NASDAQ:SNY)BNP Paribas Financial Markets raised its position in Sanofi (NASDAQ:SNY - Free Report) by 3,440.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,033,549 shares of the company's stock after purchasing an additional 1,0July 4, 2024 | reuters.comBpifrance eyes investment in Sanofi's consumer health businessJuly 4, 2024 | investorplace.comUpcoming Stock Spinoffs: Should You Pounce or Pass?July 3, 2024 | investorplace.com7 Safe Haven Stocks to Buy Before the Next Market CorrectionJuly 3, 2024 | marketwatch.comSanofi, Regeneron Pharmaceuticals get EU approval for anti-inflammatory drugJuly 3, 2024 | reuters.comEU approves Sanofi's Dupixent for 'smoker's lungs'July 3, 2024 | globenewswire.comPress Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPDJuly 2, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Shares Sold by Eagle Ridge Investment ManagementEagle Ridge Investment Management decreased its stake in Sanofi (NASDAQ:SNY - Free Report) by 83.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,368 shares of the company's stock after selling 26,977 shares duriJuly 1, 2024 | reuters.comSanofi eyes German insulin investment of up to $1.6 bln, source saysJuly 1, 2024 | reuters.comSanofi eyes investment of up to $1.6 bln in Germany, Handelsblatt saysJune 27, 2024 | reuters.comGerman vaccine panel endorses Astra-Sanofi's RSV shot for infantsJune 26, 2024 | globenewswire.comPress Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJMJune 26, 2024 | reuters.comSanofi-backed Formation Bio raises $372 million in late-stage funding roundJune 26, 2024 | benzinga.comSanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVCJune 25, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Shares Acquired by Dynamic Advisor Solutions LLCDynamic Advisor Solutions LLC lifted its position in Sanofi (NASDAQ:SNY - Free Report) by 39.2% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 57,204 shares of the company's stock afJune 25, 2024 | globenewswire.comPress Release: Availability of the Q2 2024 Aide-mémoireJune 22, 2024 | marketbeat.com27,449 Shares in Sanofi (NASDAQ:SNY) Purchased by BTC Capital Management Inc.BTC Capital Management Inc. purchased a new stake in Sanofi (NASDAQ:SNY - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 27,449 shares of the company's stock, valued at approximately $1,334,000. A number oJune 21, 2024 | marketbeat.comSanofi (NASDAQ:SNY) Sees Strong Trading VolumeSanofi (NASDAQ:SNY) Sees Large Volume IncreaseJune 21, 2024 | globenewswire.comPress Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi's Executive CommitteeJune 21, 2024 | globenewswire.comPress Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Brace Yourself: Experts calling for Bitcoin to hit $100k (Ad)For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon. Click here to get The Crypto Bull Run Millionaire Blueprint now. SNY Media Mentions By Week SNY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNY News Sentiment▼0.620.62▲Average Medical News Sentiment SNY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNY Articles This Week▼209▲SNY Articles Average Week Get Sanofi News Delivered to You Automatically Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PFE News BMY News GSK News NVS News BIIB News AZN News MRNA News TAK News TEVA News BGNE News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNY) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sanofi Please log in to your account or sign up in order to add this asset to your watchlist. Share Sanofi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
